Last reviewed · How we verify

NCT05268523

Self-Management Interventions for Long COVID-19

Recruiting now NA Last updated 25 November 2024
What this trial tests

NA trial testing Education and Strategies Intervention in COVID-19 in 270 participants. Currently enrolling.

Timeline
23 November 2021
Primary endpoint
1 June 2025
1 December 2025

Quick facts

Lead sponsorToronto Rehabilitation Institute
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment270
Start date23 November 2021
Primary completion1 June 2025
Estimated completion1 December 2025
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Toronto Rehabilitation Institute

Who can join

18 and older, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate and compare the feasibility and efficacy of two group-based interventions (education vs. mindfulness) to help self-manage Long-COVID symptoms.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Neurological, psychological, psychosocial complications of long-COVID and their management.
    Narayanan SN, Padiyath S, Chandrababu K, Raj L, et al · · 2025 · cited 7× · PMID 39516425 · DOI 10.1007/s10072-024-07854-5
  2. Effectiveness of a personalised self-management intervention for people living with long covid (Listen trial): pragmatic, multicentre, parallel group, randomised controlled trial.
    Busse M, Pallmann P, Riaz M, Potter C, et al · · 2025 · cited 6× · PMID 40046291 · DOI 10.1136/bmjmed-2024-001068
  3. Self-managing symptoms of Long COVID: an education and strategies research protocol.
    Rybkina J, Jacob N, Colella B, Gold D, et al · · 2024 · cited 4× · PMID 38384879 · DOI 10.3389/fpubh.2024.1106578

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

Other Toronto Rehabilitation Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05268523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing